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Am J Geriatr PsDelirium is a serious and common acute neuropsychiatric syndrome that is associ-
ated with short- and long-term adverse health outcomes. However, relatively little
delirium research has been conducted in unselected populations. Epidemiologic
research in such populations has the potential to resolve several questions of clinical
signiﬁcance in delirium. Part 1 of this article explores the importance of population
selection, case-ascertainment, attrition, and confounding. Part 2 examines a speciﬁc
question in delirium epidemiology: What is the relationship between delirium and
trajectories of cognitive decline? This section assesses previous work through two
systematic reviews and proposes a design for investigating delirium in the context of
longitudinal cohort studies. Such a design requires robust links between community
and hospital settings. Practical considerations for case-ascertainment in the hospital,
as well as the necessary quality control of these programs, are outlined. We argue that
attention to these factors is important if delirium research is to beneﬁt fully from
a population perspective. (Am J Geriatr Psychiatry 2013; -:-e-)
Key Words: Delirium, dementia, epidemiology, systematic reviewpidemiology is concerned with interrelationshipsEbetween populations, exposures, and outcomes.
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The Population Epidemiology of Delirium What is the natural history? How long might it
last? What are the long-term outcomes? Are any
adverse sequelae independent of the general
consequences of systemic illness, trauma,
surgery, or drug treatments?
 Is there an association with dementia? How
strong is this association? Does delirium affect
trajectories of cognitive decline?
Most of these questions have been addressed by
studies in a range of settings. However, very little
delirium research has been undertaken from a pop-
ulation-based perspective. This is essential if we
hope to contextualize the many strands of investi-
gation, otherwise limited by virtue of selected
samples, within a common denominator.1
This article includes two parts: (1) a theoretical
framework for epidemiologic research relevant to all
older adults, namely: population selection, case-
ascertainment, attrition (loss to follow-up), and con-
founding; and (2) a discussion on a critical question in
delirium research: What is the relationship between
delirium and trajectories of cognitive decline?
Accordingly, it includes two systematic reviews: (1)
the descriptive epidemiology of delirium in
population-based studies; and (2) the impact of
delirium on cognitive outcomes. These identify gaps,
which lead to recommendations on how such an
epidemiologic study of delirium and trajectories of
cognitive decline might be practically achieved. We
consider how to standardize and quality-control
assessments of individuals with delirium. Thus,
a range of speciﬁc clinical and organizational questions
can be addressed.PART 1: CHALLENGES IN THE
EPIDEMIOLOGY OF PSYCHIATRIC
SYNDROMES
Understanding the Provenance of Populations
and Sample Selection
In considering the importance of deﬁning a pop-
ulation, we are asking: Is the chosen population repre-
sentative of the full spectrum of persons with delirium
in that population? For example, if we are studying
incidence of postoperative delirium in patients aged
70 years and older with urinary tract infections, are the
individuals in the study representative of everyonewith2delirium or are there biases that arise because this is
a relatively easy group to identify and recruit? How
does the approach to sampling enable a valid capture of
the chosen population? These are critical questions
because the provenance of the sample population has
the potential to systematically bias ﬁndings both in
magnitude and direction.
The majority of studies in delirium have been
undertaken in speciﬁc hospital settings and often
among patients with particular medical or surgical
conditions.2,3 Together, these studies indicate that
delirium is a common problem in inpatients and is
associated with serious adverse outcomes, such as
increased mortality, institutionalization, and
dementia. However, there are three limitations to the
inferences that can be drawn about delirium as
a whole in the existing literature. First, one cannot
assume that all persons with delirium from a given
population will actually present to the particular
hospital from which the respondents come. Second,
once in the hospital, there is only retrospective
information on a person’s cognitive and functional
status. This lack of reliable data on preadmission
status makes it difﬁcult to ascertain delirium (and
pre-existing dementia) because the diagnosis requires
determination of acute change in mental status.
Third, the referral and selection bias inherent in
hospital-based studies with particular subgroups of
people with delirium leads to questionable general-
izability or often conﬂicting ﬁndings across studies.
An example of the importance of working with an
unselected population is evident from the ﬁndings of
the Oxfordshire Community Stroke Project (OCSP)4,5
and its successor, the Oxford Vascular Study
(OXVASC).6 A working deﬁnition for population-
based study might be: “a study where all
subgroups of the population are sampled, regardless
of disease or residential status.”7 These studies of
stroke incidence made comprehensive efforts to
ascertain all cases of transient ischemic attack (TIA)
or stroke from a deﬁned population registered at
general practitioners’ (GP) ofﬁces, where virtually all
primary care in the United Kingdom is delivered.
Each participating surgery (clinic) maintained close
personal contact with the study, and collaborating
GPs reported suspected cases to the study as soon as
patients presented. If participants were not admitted
to the hospital directly, they were assessed on the day
of referral in a dedicated research clinic or at theAm J Geriatr Psychiatry -:-, - 2013
BOX 1. Diagnostic and Statistical Manual of Mental
Disorders, Fourth Edition, Criteria for Delirium
A. Disturbance of consciousness (i.e., reduced clarity of awareness
of the environment) with reduced ability to focus, sustain, or
shift attention.
B. A change in cognition or the development of a perceptual
disturbance that is not better accounted for by a pre-existing,
established, or evolving dementia.
C. The disturbance develops over a short period of time (usually
hours to days) and tends to ﬂuctuate during the course of the
day.
D. There is evidence from the history, physical examination, or
laboratory ﬁndings that the disturbance is caused by the direct
physiologic consequences of a general medical condition.
Davis et al.participant’s own home. All computerized diagnostic
codes were reviewed, strengthened by record linkage
systems between primary and secondary care.
Hospital and emergency department presentations
were reviewed daily, and all deaths out of hospital
were identiﬁed via the coroner’s ofﬁce.
This strategy to include all cases from the general
population resulted in great advances in under-
standing the prognosis and outcomes from TIA and
stroke, precisely because it included the full range of
persons with acute neurovascular events. In
a systematic review of studies reporting the risk of
early stroke after TIA, it is clear that population-
based studies had much higher estimates of early
recurrence (within 7 days) compared with those
samples presenting solely to specialist stroke services
(proportion (95% conﬁdence interval [CI] recurring
within 7 days in population-based studies versus
specialist stroke services: 10.4% [8.1e12.6)] versus
0.9% [0.0e1.9], respectively).8 It is now clear that the
relationship between TIA and early stroke can be
predicted by using a clinical risk score.9,10 These
ﬁndings had a major impact in the planning of stroke
services and in improving outcomes for patients.11
For delirium research, we need to consider how
explicitly the population is deﬁned. To understand
how delirium relates to adverse cognitive outcomes,
an optimal design would start with a broad, unse-
lected denominator (i.e., a true population-based
study) followed up with serial cognitive, mood, and
functional assessments. This method would result in
the identiﬁcation of a comprehensive range of
symptoms and severities, and would establish what
happens, to whom, and when. Of course, ensuring
that a study population is comprehensive in this way
requires substantial effort, but there are gains of
equal degree in terms of achieving results with
external generalizability.Case Ascertainment in Research: Problems With
Respect to Delirium
To reliably track states of health in populations, the
deﬁnition of exposures and outcomes of interest must
be standardized. For psychiatric syndromes, the
reference-standard deﬁnition is necessarily a set of
clinically agreed on descriptions of psychopathology
rather than any objective measures. However, the
possibility that biomarkers might eventuallyAm J Geriatr Psychiatry -:-, - 2013contribute to case-ascertainment is reviewed in the
following discussion.
From deﬁnition to operationalization. There are some
differences between the International Classiﬁcation of
Diseases (World Health Organization) and the Diag-
nostic and Statistical Manual of Mental Disorders (DSM)
(American Psychiatric Association) deﬁnitions of
delirium, and these have an impact on case-ascer-
tainment.12e14 These deﬁnitions evolve with each
revision and are therefore not stable over time. More
problematic is that these clinical criteria have the
potential to be interpreted differently by individual
clinicians. For example, the threshold for impairment
on cognitive testing in delirium may decrease with
age, in line with a belief that some deﬁcit is expected,
and thus not abnormal, in older age.15
It is worth examining the precision of the Diag-
nostic and Statistical Manual of Mental Disorders, Fourth
Edition, Text Revision, description, exploring the
difﬁculty with using the deﬁnition for standardizing
case-ascertainment in research. Although successive
revisions are supposed to be based on epidemiologic
ﬁeld testing, only two studies were conducted in
tertiary hospital samples (total n ¼ 560) for Diagnostic
and Statistical Manual of Mental Disorders, Fourth
Edition (DSM-IV).13,16
Deﬁcits in attention have been recognized as a core
diagnostic feature since publication of Diagnostic
and Statistical Manual of Mental Disorders, Third
Edition Revised (DSM-III-R) (Criterion A) (Box 1).
It supplanted the previous description “clouding of
consciousness” because the latter term was regarded
as being too imprecise.17 However, it is not clear what
should constitute a minimum threshold for atten-
tional deﬁcits in the diagnosis of delirium using DSM-
III-R and above.18 Moreover, patients who present3
TABLE 1. Clinical Features in Delirium Not Currently Deﬁned by DSM Criteria With a Theoretical Inﬂuence on Determining
Prognostic Categories
Effect on Prognosis Comment References
Motoric subtypes Hypoactive delirium associated with higher
mortality, especially with co-morbid
dementia
Motoric assessment, including accelerometer-based
measures have scope to inform prognostic
categories
79e81
Duration Minimum and maximum duration unclear Delirium may evolve into dementia. Short-term versus
persistent delirium proposed in DSM-5 (threshold
not speciﬁed)
Temporal ﬂuctuations Specifying short ﬂuctuations (hours) favors
identiﬁcation of hyperactive over
hypoactive subtype
Hypoactive delirium has poorer prognosis; therefore,
any speciﬁcation of temporal ﬂuctuations should
take this into account
Severity Clinical rating scales in existence (e.g., DRS-
98, MDAS, Delirium Index). Higher scores
associated with worse outcomes
Categories of severity might be incorporated into
diagnostic criteria
82
Subsyndromal delirium Higher mortality and worse cognitive
outcomes compared to normal controls
Variably deﬁned; represents a state between
normality and full delirium syndrome. Current
deﬁnition of delirium might perhaps be broadened
to include milder deﬁcits
83, 84
Notes: DRS-98: Delirium Rating ScaleeRevised-98; DSM-5: ﬁfth edition of the Diagnostic and Statistical Manual of Mental Disorders;
MDAS: Memorial Delirium Assessment Scale.
The Population Epidemiology of Deliriumwith a reduced level of consciousness in an acute
setting are often not included in delirium studies if the
severity of their impairments means that they cannot
undergo cognitive testing. These two unresolved but
crucial issues reﬂect the general scarcity of research on
the neuropsychology of delirium.19
Diagnostic and Statistical Manual of Mental Disorders,
Fourth Edition, Text Revision, also requires a change in
cognition or perceptual disturbance (Criterion B).
However, the extent to which delirium may have
a differential effect on domains of cognition or
perception is complex and not speciﬁed. Neuropsy-
chiatric symptoms such as motor 20 or sleepewake21
disturbance are frequently present but not speciﬁc for
delirium. Affective symptoms, thought disorder, and
perceptual disturbances are also recognized as part of
Criterion B, and operationalizing these features
would serve to maximize sensitivity of detection.
Criterion C states that symptoms should be acute
(hours to days) and ﬂuctuate over the course of the
day. These features are highly speciﬁc to delirium.
However, by their nature, they make ascertainment
more difﬁcult because a test score may vary over
periods of hours or even minutes. Multiple assess-
ments per day could increase detection of deﬁcits as
well as eliciting ﬂuctuation but may be impractical.
Currently, best practice is to use tools that attempt to
capture relevant information (e.g., informant history,
clinical case notes) in the period preceding the
assessment.4Specifying that delirium is due to an underlying
medical disorder fulﬁlls Criterion D. However, it is
unclear what should actually constitute “evidence”
for cause and effect. For the vast majority of cases,
acute medico-surgical events (e.g., urinary tract
infection) and delirium are temporarily linked.
However, because the pathophysiology of delirium
remains elusive,22 level of evidence for etiologic links
remains subject to scepticism. In addition, often
multiple etiologies are demonstrable over the course
of delirium23 but may be unidentiﬁable inw10%.24 It
is not known if the precipitant inﬂuences the phe-
nomenologic presentation.
Delirium and dementia. The boundaries for the
delirium syndrome become more complex when
considering co-morbid dementia. DSM separates the
delirium and dementia deﬁnitions, but the problem
of identifying one superimposed on the other
remains. This is crucial because delirium can be
missed, under an assumption that observed cognitive
deﬁcits are due to dementia. When delirium and
dementia co-exist, the delirium symptoms (e.g.,
prominent inattention with ﬂuctuating deﬁcits) are
thought to dominate the presentation over the
impairments seen in dementia; this theory has been
reviewed in detail elsewhere.24e26 However, much of
the delirium ﬁeldwork explicitly excluded persons
with dementia; therefore, the resultant conceptuali-
zation overemphasizes features that are more likely
to be reported in cognitively intact personsAm J Geriatr Psychiatry -:-, - 2013
TABLE 2. Theoretical Mechanisms for Missing Data
Deﬁnition Example Implications for Delirium Research
MCAR Does not depend on observed or
unobserved data
Lost data due to technical error
such as miscalibration of MRI
machine
Missing data are ignorable, but this is a rare situation
MAR Depends on observed data Unable to tolerate MRI sequences,
predictable from knowledge of
participant’s cognition or ADL
Other parameters may explain the mechanism of
missingess but not fully enough to provide
unbiased estimates in analyses
MNAR Depends on the value the outcome
would have taken had it been
observed
Attrition through death, driven by
incident delirium or dementia
that was not captured by the
follow-up schedule
The most common mechanism of missing data in
aging research. Requires speciﬁc and robust
mechanisms for case-ascertainment, with statistical
analyses to account for attrition
Notes: ADL: activities of daily living; MAR: missing at random; MCAR: missing completely at random; MNAR: missing not at random;
MRI: magnetic resonance imaging.
Davis et al.(e.g., psychotic symptoms). Conversely, delirium
scales that include assessments of memory or other
cognitive deﬁcits known to be present in dementia
(such as the Delirium Rating ScaleeRevised-98)27
may be confounded by the presence of dementia.
Moreover, some delirium assessment instruments
have been validated in groups from which dementia
patients were excluded. One consequence is that
individuals perform poorly on the memory subscale
because of dementia, regardless of whether delirium
is also present. Currently, it is not known if delirium
and dementia can be distinguished in a cross-
sectional assessment on cognitive and phenomeno-
logic grounds alone, but some studies suggest that
this might be possible.28e30
The chief difﬁculty with operationalizing delirium
is that the boundaries of the main constructs are not
clearly deﬁned. DSM does not specify duration,
severity, minimum thresholds, or which symptoms
should ﬂuctuate over which time frames. However,
empiric data suggest that each of these parameters
may inﬂuence outcomes and therefore perhaps
deﬁne prognostic groups (Table 1).24,26 Further
detailed population-based ﬁeldwork involving
increased use of standardized deﬁnitions and
measurements with objective high reliability is
essential if case deﬁnitions are to describe useful
phenotypes. Despite these limitations, in the research
setting, the aim is to operationalize these criteria so
that case-ascertainment can be achieved in a consis-
tent manner.
Biomarkers and psychiatric syndromes. Biomarkers
have been widely considered in dementia, for
example, in the hope that a greater understanding ofAm J Geriatr Psychiatry -:-, - 2013dementia pathophysiology might be able to
contribute to case-ascertainment or even supplant the
current clinical reference standard.31e33 There has
been substantial progress in the ﬁeld; for example,
identifying amyloid burden in vivo34 and putative
markers of neurodegeneration, among others.35,36
However, such work has only ever been generaliz-
able to the selected populations able to tolerate
procedures such as positron emission tomography/
magnetic resonance imaging or lumbar puncture.1
There is a real need for biomarker research to be
validated within the context of a general population
before they can be proposed as part of a new
reference standard. Current plasma biomarker
candidates such as apolipoprotein E, insulin-like
growth factor-1, and S-100b for predicting delirium
risk, prognosis, or severity have recently been
reviewed.37 Other candidate biological correlates of
delirium include electroencephalogram,38 neuro-
imaging,39 and markers in cerebrospinal ﬂuid.39 It is
clear that biomarkers in delirium are still in their
infancy, but advances in our understanding of
delirium pathophysiology may eventually help to
reﬁne case-ascertainment.
In conclusion, the optimal operationalization of
DSM-IV for delirium would require: (1) a reliable and
valid test of inattention; (2) reliable and valid assess-
ments of cognition and neuropsychiatric symptoms;
and (3) temporal nature of acute change captured by
regular observation, with or without a contribution
from informants. Ultimately, validation studies of
biomarkers could be undertaken in unselected pop-
ulations, serving to improve delirium knowledge at
the clinical and population levels.5
The Population Epidemiology of DeliriumDropout in Studies of Older Adults: Accounting
for Attrition
Loss to follow-up is common to all longitudinal
studies of older persons. Reasons for loss of follow-
up include dropout and death between interviews.
This is also known as censoring, where individuals
contribute to the observed period of follow-up but
where loss to follow-up means that case status cannot
then be ascertained. There is a clear effect on how
accurately associations with outcomes can be made.
Elaborating how these biases can be addressed is
relevant for all follow-up studies of delirium.
It is important to explore possible reasons why
outcome data may be missing. This involves consid-
ering whether the fact that data are missing might be
associated with any other variables known (and
unknown) in the study. Three characterizations of
missing data mechanisms have been proposed:
missing completely at random, missing at random
(MAR), and missing not at random (MNAR)
(Table 2).40 Data MNAR is the most likely mechanism
to operate in longitudinal studies of aging, where the
probability of an individual not being seen at
a certain occasion depends on the individual’s
delirium status (unobserved) at that same occasion.
Several approaches are available to analyze incom-
plete data. The simplest method consists of excluding
cases with missing observations. This method, known
as complete case analysis, is a very inefﬁcient way of
analyzing data and does not make use of all available
information. Because data in longitudinal studies of
older persons are unlikely to be missing completely at
random, such an approach will bias the analysis in
favor of better-performing participants. This illustrates
why missing data cannot simply be ignored; the very
fact that some data are missing is informative, and an
appropriate analysis must be adopted.
Other ad hoc methods are based on the idea of
“ﬁlling in” or imputing missing values to complete
the data. Imputation has been proposed as a method
of accounting for missing data on exposures (inde-
pendent covariates) and outcomes (dependent vari-
ables). However, it should be noted that imputing
outcomes is intrinsically problematic. This is because
studies aim to determine a given outcome, and
arguably, it would be unsatisfactory for this to be
simulated. Methods include: last-observation-carried-
forward imputation, regression mean imputation,6and multiple imputation. For example, if a study
examining the relationship between delirium (inde-
pendent variable) and pressure sores (dependent
variable) had data missing due to participants being
too drowsy to participate in cognitive testing. Here,
imputation could be used to account for these
missing data points by estimating new values
according to the pattern of loss in relation to other
covariates in the model (e.g., illness severity).
If imputation for missing outcome data is to be
avoided, other analytical approaches are recom-
mended. If we are prepared to assume missing data
are MAR, random-effects modeling is a statistical
technique that produces robust estimates and uses all
available data. However, if we believe that an MNAR
mechanism might be a more reasonable assumption
to make, then more sophisticated statistical tech-
niques such as shared parameter models might be the
most adequate method of analysis.41 The use of these
techniques is not widespread in the literature on
aging, but researchers who believe that a MAR
assumption is not valid in their studies (because
information on delirium “missingness” is not in the
model [e.g., attrition due to higher delirium-speciﬁc
mortality]) should consider applying these more
reﬁned analytical methods. Although these
approaches have been important in dementia epide-
miology, they have yet to be applied systematically
to follow-up studies of delirium, which almost
certainly underestimate the effect of dropout.42e44
Accounting for Predisposing and Precipitating
Factors: Residual Confounding?
Observational epidemiology seeks to identify asso-
ciations between exposures (independent variables)
and outcomes (dependent variables). Delirium can be
regarded in both contexts. For example, deliriummight
be modeled as an exposure, with dementia as an
outcome. Alternatively, sometimes delirium is consid-
ered the outcome, inwhich, for example, statin therapy
is the exposure. These analyses should be undertaken
with attention to the possibility of confounding.
The psychiatric formulation identiﬁes two dimen-
sions that need to be accounted for when considering
prospective associations in delirium studies: precipi-
tating and predisposing factors. Precipitating factors
include measures of acute illness severity (which may
include measures of intensity of surgery), andAm J Geriatr Psychiatry -:-, - 2013
Davis et al.predisposing factors include cognitive impairment
and frailty. There is an inverse relationship between
these two dimensions: relatively minor illness
precipitants may result in delirium given predispos-
ing dementia.45 This is clinically intuitive and has
long been supported by empiric data.46
Can we account for the effects of predisposing and
precipitating factors so that we can assess the inde-
pendent associations with delirium? In other words,
is delirium directly responsible for the association in
question or is it a marker for some more funda-
mental, less-measurable mechanism? This problem
was recognized in a systematic review of outcomes
after delirium in hospitalized patients, in which one
of the inclusion criteria was that studies should have
adjusted for co-morbid illness or illness severity.3
The review considered predisposing and precipi-
tating factors together, and the individual studies
operationalized these dimensions as follows:
 Predisposing factors: for example, presence of
dementia or cognitive test score such asMMSE and
the Informant Questionnaire on Cognitive Decline
in the Elderly; Charlson co-morbidities index;
functionalmeasures suchas activities of daily living.
 Precipitating factors: for example, acute physi-
ology and chronic health evaluation II (APACHE
II) score (Acute Physiology scale); physiologic or
metabolic parameters: systolic blood pressure, C-
reactive protein, urea, creatinine.
 Scales combining assessments of both factors: for
example, the Burvill scale (a physician judg-
mentebased scoring of several organ systems in
which severity of acute and chronic conditions
and their contribution to disability are assessed).
All studies made an attempt to adjust for predis-
posing factors, suggesting that it is easier to operation-
alize this dimension. To account for illness severity,
many studies used APACHE II as a measure of both
predisposing and precipitating factors, which has
never been validated outside the intensive care unit
or in older persons.47 The other approach to adjusting
for illness severity was to use a marker of overall
metabolic or physiologic derangement (e.g. C-reactive
protein levels, elevated urea/creatinine ratio).
Very few prognosticmodels formortality have been
validated in individuals aged 50 years and older.47
Perhaps the most well established is the Charlson
co-morbidities index,48 which provides a weighted
score representing co-morbidities (and thereforeAm J Geriatr Psychiatry -:-, - 2013chronic predisposing factors). One problem is that the
weightings and the conditions were validated more
than 20 years ago, and secular trends may therefore
limit its validity. For example, a diagnosis of acquired
immunodeﬁciency syndrome scores the same as
metastatic disease, and peptic ulcer disease is
weighted the same as congestive heart failure.
Overall, the question remains as to how to reliably
detect and,where possible, quantify acute precipitating
factors in delirium. Another approach from the acute
internal medicine literature examines “early warning
scores.” The best performing tool to date is the Vital-
PAC earlywarning score.49 Thiswas devised to predict
in-hospital mortality within 24 hours of acute admis-
sion and uses a weighted aggregate of seven parame-
ters: pulse rate, respiratory rate, temperature, systolic
blood pressure, oxygen saturation, inspired oxygen,
and level of consciousness. The model was validated
on 35,585 patient episodes, and the median age was 68
years. This approach has not been considered before in
delirium but could be valuable. However, many of
these indicators may not perform in the same way in
older people,50 and measures of level of consciousness
overlap with many symptoms of delirium.
In Part 1, we outlined a theoretical framework of
epidemiologic principles. Attention to population
selection, case-ascertainment, attrition, and confound-
ing is vital if delirium is to be investigated in a valid
and reliable way. Part 2 identiﬁes gaps in the existing
literature with regard to these concepts, proposing
some recommendations for addressing a speciﬁc
question in delirium epidemiology: the relationship
between delirium and trajectories of cognitive decline.PART 2: EPIDEMIOLOGIC APPROACHES
TO DELIRIUM AND TRAJECTORIES OF
COGNITIVE DECLINE
This section focuses on the methodologic issues
central to a key question in delirium research: what is
its relationship with trajectories of cognitive decline?
This question has wide-ranging biological, clinical,
and public health implications. If delirium is robustly
associated with trajectories of cognitive decline,
then delirium prevention might plausibly have an
impact on dementia prevention. Therefore, demon-
strating an association with morbidity and economic
costs, and quantifying these relationships within7
BOX 2. MEDLINE (Ovid SP) search strategy
Systematic review 1
1. exp Delirium/ep [Epidemiology]
2. delirium.mp or “acute confusion”.mp or “metabolic
encephalopathy”.mp
3. community or population
4. prevalence or incidence
5. (#1 OR #2) AND #3 AND #4
Systematic review 2
1. exp Delirium/ep [Epidemiology]
2. delirium.mp or “acute confusion”.mp or “metabolic
encephalopathy”.mp
3. (cogniti*) AND (trajector* or decline or impairment)
4. dementia
5. (#3 OR #4)
6. (prospective or cohort)
7. (#1 OR #2) AND #5 AND #6
The Population Epidemiology of Deliriuma population-based setting, presents a strong case for
such epidemiologic research.
Before setting out how a study of this nature might
be achieved, two systematic reviews are presented,
one on population-based descriptive epidemiology
and one on cognitive outcomes after delirium in
prospective studies, which together provide an indi-
cation of the quantity and quality of previous work in
this ﬁeld. The ﬁrst reviews population-based studies
reporting the descriptive epidemiology of delirium
(in the section entitled “Descriptive Epidemiology of
Delirium in Population-Based Studies”). The second
reviews cohort studies reporting the impact of
delirium on trajectories of cognitive decline in which
adverse cognitive sequelae can be reliably assessed
with reference to pre-morbid cognitive assessments
(in the section entitled “Delirium and Cognitive
Trajectories”). It is proposed that these different
methods could be eventually combined in a unifying
population-based study.
The last part of this section suggests practical
approaches to case-ascertainment in epidemiologic
studies, including the quality control of this process.Systematic Reviews
Methods. Both reviews shared a common
protocol, following the meta-analysis of observa-
tional studies in epidemiology guidelines.51
Eligibility criteria
Descriptive epidemiology: Cross-sectional (preva-
lence) or cohort (prevalence and incidence) studies
reporting delirium measures were considered.
Studies were required to deﬁne delirium according to
a standardized classiﬁcation system and be con-
ducted in groups sampled from the whole population
unrestricted by residential or health status.
Cognitive trajectories: All prospective studies
reporting delirium and subsequent cognitive
impairment were eligible for inclusion. The study
design needed to compare cognitive function before
delirium with impairments afterward. Premorbid
cognitive function must have been assessed by use of
a neuropsychological evaluation. Retrospective esti-
mates of premorbid cognition (e.g., Informant Ques-
tionnaire on Cognitive Decline in the Elderly, AD8)
were not regarded as sufﬁciently reliable. There was
no requirement for the population to be sampled in
an unselected manner.8Search strategy and data extraction
A systematic search of MEDLINE, Embase, and the
Science Citation Index (all from 1980eDecember 31,
2012) was conducted (Box 2). Studies before 1980 were
not considered because such work would have pre-
dated Diagnostic and Statistical Manual of Mental Disor-
ders, Third Edition, and therefore would be unlikely to
report standardized case-deﬁnitions. Comprehensive
text word, Medical Subject Headings, and Emtree
terms were used to ﬁnd relevant studies. Bibliogra-
phies of included articles and other reviews were
screened, including use of forward matching. Three
authors (D.H.J.D., A.J.H., A.M.) independently
screened articles for inclusion. Estimates of prevalence
and effect sizes in relation to cognitive outcomes (and
their standard errors) were extracted, along with any
relevant clinical variables, speciﬁcally: age, gender, and
education (where reported).
Data analysis
Statistical analyses were performed by using Stata
version 12.1 (Stata Corp, College Station, TX).
Descriptive epidemiology: The range of different
populations identiﬁed across the studies justiﬁed use
of random-effect models for pooling the estimates.52
95% CIs were calculated, and statistical heteroge-
neity was assessed by using the s2 statistic.
Cognitive trajectories: These results were summa-
rized in a narrative manner.
Descriptive Epidemiology of Delirium in
Population-Based Studies
The identiﬁcation, assessment, and selection of
articles for inclusion is shown in the PRISMA
ﬂow diagram (Fig. 1). Three studies reportedAm J Geriatr Psychiatry -:-, - 2013
FIGURE 1. PRISMA ﬂow diagram.
Davis et al.point-prevalence, and two reported period-
prevalence (1 month and 3 years) of delirium. No
population-based studies explicitly observing partic-
ipants for incident delirium were identiﬁed. Charac-
teristics of these studies are summarized in Table 3.
Point-prevalence studies. All studies reporting
point-prevalence used a basic screening measure,
with more detailed characterization of screen-
positive participants and a random subsample of
screen-negative participants. The East Baltimore
Survey 53 identiﬁed 6 cases of prevalent delirium,
giving an age-speciﬁc prevalence of 10.9 (95% CI:
0.0e22.5) per 1,000 persons aged 55 years and older.
It is not clear if any of these cases had co-existent
dementia. A door-to-door survey of 1,460 individ-
uals aged 70 years and older yielded 14 cases of
delirium (prevalence ¼ 9.6 [95% CI: 4.4e14.9] per
1,000 persons), 12 of whom also had dementia. The
prevalence of delirium in persons with dementia was
much higher: 79.5 (95% CI: 35e126) per 1,000
persons.54 The Canadian Study of Health and AgeingAm J Geriatr Psychiatry -:-, - 2013applied DSM-III-R diagnoses at consensus meetings
after two independent neuropsychological evalua-
tions.55 Diagnoses of delirium and dementia were
considered mutually exclusive. The 21 delirium cases
identiﬁed represented a point-prevalence of 6.3 (95%
CI: 4.1e9.6) per 1,000 persons.
Period-prevalence studies. The Gerontological
Regional Database (GERDA) study sampled women
aged 85 years and older, and diagnoses pertaining to
delirium in the previous month were decided by
a geriatrician with access to all study neuro-
psychological evaluations, informant, and caregiver
interviews and medical records, based on DSM-IV
criteria.56 The 1-month period prevalence for
deliriumwas 272 (95%CI: 235e312) per 1,000 persons.
Delirium prevalence was strongly associated with age
(85e89 years, 19%; 90e94 years, 24%; 95 years and
older, 39%) and dementia (odds ratio [OR]: 5.8 [95%
CI: 3.5e9.5] for clinical Alzheimer disease).
The Vantaa 85þ study ascertained delirium in the 3
years between baseline interview and follow-up by9
TABLE 3. Characteristics of Studies of Delirium Prevalence in the General Population
Population and Setting Design Delirium Ascertainment
Point-prevalence
East Baltimore Mental
Health Survey53
Census blocks, random sample
18e64 years old and all residents
age 65 years and older
NIMH DIS, with clinical assessment
of random subsample (n ¼ 398)
and any others with positive DIS
response (n ¼ 412)
Standardized Psychiatric
Examination and psychiatric
assessment (DSM-III and ICD-9)
CSHA55 Random sample of all adults age 65
years and older clustered in ﬁve
regions of Canada, over sampling
adults age 75 years and older
Clinical examination of random
subsample (n ¼ 2,914) including
all institutionalized adults and
screen-positives for cognitive
impairment (3MS <78/100)
DSM-III-R applied at consensus
conference based on
neuropsychiatric evaluation
from nurse and physician.
Delirium given as primary
diagnosis if no underlying
dementia diagnosis
Girona54 Door-to-door sampling of adults age
70 years and older (n ¼ 1,581
eligible)
All screened participants (n ¼
1,460) with MMSE scores <24
(n ¼ 335) and random sample
with MMSE scores 24 (n ¼ 314)
Neurologist- and psychologist-
administered CAMDEX
Period-prevalence
GERDA56 All women aged 90 years and older,
50% of those aged 85e89 years
All participants (n ¼ 503) examined
by using MMSE and OBS scale
DSM-IV applied based on study
information, informant/caregiver
interviews, medical records
(1-month period)
Vantaa 85þ57 Recruitment of all adults resident in
Vantaa aged 85 years and older
(n ¼ 601 eligible)
All participants assessed with
informant, with clinical,
cognitive, and functional
examinations
History of delirium established by
retrospective interview of
participant and informant with
reference to medical case notes
Notes: 3MS: Modiﬁed MinieMental State Examination; CAMDEX: Cambridge Mental Disorders of the Elderly Examination; CSHA:
Canadian Study of Health and Aging; DIS: Diagnostic Interview Schedule; DSM-III: Diagnostic and Statistical Manual of Mental Disorders, Third
Edition; DSM-III-R: Diagnostic and Statistical Manual of Mental Disorders, Third Edition Revised; DSM-IV: Diagnostic and Statistical Manual of
Mental Disorders, Fourth Edition; GERDA: Gerontological Research Database study; ICD-9: International Classiﬁcation of Diseases, Ninth Revision;
MMSE: MinieMental State Examination; NIMH: National Institute of Mental Health; OBS: organic brain syndrome scale.
The Population Epidemiology of Deliriumassessing participants, along with their informant(s),
for a history of any episodes of delirium based on an
operationalization of the DSM-III-R criteria.57 The re-
ported history was corroborated with hospital case
notes that were available at the time of assessment.
Deliriumwas reported to have occurred in 100 (95%CI:
66e150) per 1,000 persons surviving to ﬁrst follow-up.
The estimates of point-prevalence are summarized
in Figure 2. There is a consistent ﬁnding that pop-
ulation prevalence of delirium is relatively low, with
an overall point-prevalence estimated at 7.2 (95% CI:
4.8e9.6) per 1,000 persons in the group aged 55 years
and older.
Comment. Because the Canadian Study of Health
and Ageing is the largest study and did not include
delirium in persons with a dementia diagnosis, the
pooled prevalence is also likely to be an underesti-
mate. In addition, it is likely that intercurrent illness
and/or delirium reduces response rates in epidemio-
logic surveys; the detected prevalence may therefore
be very lowbydesign. The period-prevalence seems to
be higher in 1-month estimates compared with 3-year10estimates (27% versus 10%) in a similarly aged pop-
ulation. This is likely to be driven by the association
between delirium and mortality, and less delirium is
thus observed in the 3-year survivors.Delirium and Cognitive Trajectories
Three reports from two cohort studies were iden-
tiﬁed. In addition, adverse outcomes in two studies
of elective surgery patients were reported. The char-
acteristics of these studies are described in Table 4.
Cohort studies. In Vantaa 85þ, a history of
delirium was associated with incident dementia at
follow-up (OR: 8.7 [95% CI: 2.1e35]).58 Delirium was
also associated with worsening dementia severity
(OR: 3.1 [95% CI: 1.5e6.3]) and with loss of 1.0 more
MMSE point per year (95% CI: 0.11e1.89) than those
with no history of delirium. In a cohort of memory
clinic patients with dementia, delirium was associ-
ated with an additional decline of 2.4 points on
the Information-Memory-Concentration scale over
6 months compared with those with no delirium.59Am J Geriatr Psychiatry -:-, - 2013
FIGURE 2. Forest plot and meta-analysis of point-prevalence studies. Estimates of delirium point-prevalence in population-based
studies are shown, along with a pooled estimate. Numbers refer to age-speciﬁc prevalence per 1,000 persons, along with
95% conﬁdence intervals (CISs). CSHA [ Canadian Study of Health and Aging.
Davis et al.These differences were consistently observed over 5
years posthospitalization.60 Both of these studies
relied on the diagnosis of delirium through retro-
spective review of medical records.
Elective surgery patients. In 200 patients under-
going hip surgery, postoperative delirium was asso-
ciated with new cognitive impairment or dementia at
3 years, even after adjustment for preoperativeMMSE
in the delirium group (OR: 41 [95% CI: 4.3e396]).61 In
a population of cardiac surgery patients, those with
delirium had signiﬁcantly lower postoperative
MMSE scores but also slower recoveries, with worse
scores at 1 and 6 months after surgery.62
Comment. These studies link baseline cognition,
delirium, and worsened cognitive function. The two
methodologic designs identiﬁed (cohort studies and
studies in elective surgery patients) have comple-
mentary strengths and weaknesses. Studies in elec-
tive surgery patients had a better opportunity to
describe the index delirium but in a more restricted
sample and usually with less information about
premorbid function. Conversely, cohort studies offer
the possibility of repeated cognitive measures, before
and after incident delirium. Moreover, cohort studies
may be sampled from the general population, as in
the case of Vantaa 85þ. The disadvantage is the
difﬁculty in prospectively capturing and character-
izing the delirium episode. In both cohort studies
identiﬁed, the delirium ascertainment relied on
interview after the event and/or retrospectiveAm J Geriatr Psychiatry -:-, - 2013examination of case notes. Although these methods
can be validated in terms of their diagnostic accu-
racy,63 they likely underestimate hypoactive forms of
delirium, as well as those who do not present to
a hospital. Nonetheless, these results are consistent
with other studies that have considered critical illness
as a proxy for delirium (and vice versa).64e66Delirium and Cognitive Decline:
Recommendations for Epidemiologic Study
Designs
Population. The conclusions from both systematic
reviews indicate that there are very few population-
based studies assessing delirium prevalence.
However, it is probable that point-prevalence of
delirium in the community is low. Nonetheless, the
value of these studies is that they describe an
approach to characterizing a base population, with
the possibility of enriching it with groups likely to
eventually yield more incident delirium cases (e.g.,
older subjects, persons with pre-existing cognitive
impairment). Therefore, although the point-
prevalence at any given moment may be low, in
persons aged 85 years and older, the 1-month period-
prevalence may be as high as 25%. More intensive
follow-up of higher risk subsamples, randomly
selected to maintain external generalizability, has
been successfully used in a number of dementia
studies and could be usefully considered here.67,6811
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The Population Epidemiology of DeliriumEssential to the recruitment of representative pop-
ulations, issues surrounding capacity and consent in
delirium studies must be addressed. The ethical
framework for approaching this topic has been
reviewed and highlights the need to protect vulner-
able participants while also asserting the equal moral
status for persons with delirium to have their
condition researched in a valid way.69 Other studies
have also demonstrated that methods used to assess
capacity, including individuals with ﬂuctuating
capacity, had an effect on the research conclusions,
depending on whether persons were included or
excluded according to capacity status.70 In some
circumstances, the use of proxy consent, especially
for low-risk studies, may be a practical option.
Case-ascertainment. From the second systematic
review, the next steps would be to establish a system
whereby acute changes in mental status can be
identiﬁed (e.g., via primary care practitioners). As in
the OXVASC study (section entitled “Understanding
the Provenance of Populations and Sample Selec-
tion”),6 this requires excellent links between hospital
and community services. Use of GPs to notify study
personnel of acute changes is likely to need dedicated
resources to be effective. A brief screening instrument
would be the ﬁrst step for case-ascertainment. It is
not known if delirium can be optimally diagnosed,
investigated, and treated in the community, and the
study should be able to determine the need for
hospitalization.
Once in secondary care, longitudinal delirium
assessments must try to account for temporal ﬂuc-
tuations. Information on delirium severity and
duration in relation to long-term outcomes would be
an important and new ﬁnding in the general pop-
ulation. The assessment of candidate biomarkers
could be incorporated both at this stage and earlier as
an assessment of delirium vulnerability. The
optimum examination schedule will be based on
resources and patient tolerability. They may range
from several (shorter) assessments several times daily
or in other settings (e.g., in long-term care, twice-
weekly assessments may be sufﬁcient).71 In addi-
tion, the frequency of assessments minimizes the risk
of misclassiﬁcation bias. Figure 3 shows how this
method increases the risk of erroneously accepting
the null hypothesis through loss of statistical power.
Other practical issues surrounding case-
ascertainment is outlined in the next section.Am J Geriatr Psychiatry -:-, - 2013
FIGURE 3. The effect of misclassiﬁcation in delirium studies. Delirium is represented by peach shading in cases; green color
indicates no delirium in cases and controls. The contingency tables demonstrate the effect of false-negative ﬁndings
when assessments are not made with enough frequency. OR [ odds ratio.
Davis et al.Attrition and missing data. Procedures for deter-
mining outcomes need to be reliable, using data from
multiple, overlapping sources. Missing data are to
some degree unavoidable, and analyses must account
for these with appropriate estimations of standard
error. The random-effects models used in the cohort
studies identiﬁed in the systematic review are
generally ﬂexible in this regard. However, missing
data may well arise when competing outcomes are at
play; for example, when dementia or death might
follow delirium. Here, data on postdelirium cognition
are “missing” because of intervening death between
resolution of the delirium and the next follow-up in
the cohort study. Techniques such as multistate or
shared parameter models can be considered.
Residual confounding. Within the assessments for
delirium and serial cognition function, other clinical
factors need to be accounted for. Measurement of
predisposing factors (e.g., age, gender, education,
functional frailty) must be embedded in the assess-
ment schedule and standardized with the same
degree of precision as the delirium and cognitive
variables. Illness severity may be more complex to
capture, but basic physiologic parameters (such as
those that comprise early warning score systems)
have the advantage of being brief, reproducible,
noninvasive, and repeatable. Repeatability is an
important dimension because these measures of
physiologic disturbance can then be tracked along-
side ﬂuctuations in delirium state.
Standardization in Delirium Research: Best
Practice for Future Research
Approaching case-ascertainment. There are several
different approaches to delirium ascertainment in use.Am J Geriatr Psychiatry -:-, - 2013These include direct application of DSM-IV criteria,
but rating scales are often used.72,73 A recent review
found 24 scales in the literature.74 These scales vary
considerably in their complexity and in the proce-
dures underpinning scoring each item. Some scales
have a small number of binary items (e.g., the
Confusion Assessment Method [CAM]), and others
have several items with three or more severity
gradations (e.g., Delirium Rating ScaleeRevised-98).
Most items in delirium scales are concerned with
recording cognitive and neuropsychiatric features
according to observations of the patient during the
interview and/or a variable period preceding the
interview. Features may be gleaned through discus-
sion with informants or through case records.
Determining the presence or absence of these
features is largely a clinical and subjective judgment.
Some items on scales involve cognitive testing; these
are more objective, but variations in how tests are
administered and scored can reduce interrater reli-
ability. In some studies, the authors have used
a package of measures, which then inform scoring on
scales, in an effort to standardize the mental status
assessment preceding this scoring.75
Clearly, no consensus exists over what instruments
should be used to capture delirium or subsyndromal
delirium, or other forms of acute mental status dete-
rioration occurring with illness, injury, or drug intox-
ication. Addressing this issue is an important priority
in delirium research. There are no clear solutions, but
it would seem reasonable to suggest the following, at
least with respect to research studies. First, cognitive
impairments are at the heart of delirium, and
measurement of cognitive impairments by using
objective tests provides meaningful data. Tests of13
The Population Epidemiology of Deliriumattention, particularly those known to be greatly
affected in delirium but not in dementia, have face
validity for this purpose.28 Cognitive data could be
reported along with binary delirium present or absent
classiﬁcations, thus providing useful information on
cognitive state that is independent of the particular
delirium assessment being used. Second, rating scales
that are anchoredwith graded behavioral descriptions
likely have greater reliability than those asking for
binary classiﬁcations. Third, in the absence of any
consensus over the meaning of severe changes in level
of alertness, but making the conservative assumption
that these changes are not likely to be independent of
delirium, more precise grading of level of alertness as
part of the assessment would likely add useful infor-
mation. This information could also be reported
independently of the delirium classiﬁcation. Such
a package of measures would take time to administer,
with associated additional costs, and empiric evalua-
tion of the meaning of these additional data with
respect to outcomes would be required before stan-
dard implementation is recommended.
Quality control in clinical studies: training protocols for
standardized case-ascertainment. Because delirium is
a clinical diagnosis, case-ascertainment by a psychia-
trist, neurologist, geriatrician, or related specialist has
been used as the reference standard in much of the
assessment literature to date. Physician expert case-
ascertainment compared with trained research
nurses using a structured assessment protocol
suggests that similar, if not improved, sensitivity and
speciﬁcity can be attained.76 Large-scale studies linked
to a community population would likely engage
nonclinical personnel for the assessment of delirium.
Currently, there is only one structured interview
available, the Delirium Symptom Interview (DSI),
with a sensitivity of 0.90 and a speciﬁcity of 0.80
compared with psychiatrists’ and neurologists’
assessment.77 Use of the DSI along with the CAM
diagnostic algorithm, after performing standardized
testing of cognition with instruments with the MMSE,
Digit Span, and the Memorial Delirium Assessment
Scale, has been reported to be reliable for nonclinicians
as part of a standardized delirium assessment.75
The standardized assessment based on DSI was
recently used in the multisite delirium prevention
ancillary study to the FOCUS Hip Fracture Trans-
fusion Trial.78 The ongoing Dexlirium study
(ClinicalTrials.gov identiﬁer NCT00561678), another14multisite, randomized postsurgical delirium preven-
tion trial, uses a similar standardized assessment
protocol. One major drawback to the standardized
assessment is its lengthy duration. In the FOCUS-
Cognition and Dexlirium studies, the assessment
can take up to 40 minutes. Also, despite the detailed
nature of the standardized protocol, the eventual
ascertainment of delirium status (e.g., based on the
CAM algorithm) still requires a degree of clinical
decision making. A reliable and valid but shorter
standardized protocol that reduces this subjectivity
for nonclinical personnel would be very useful for an
epidemiologic study of delirium.
All personnel require ongoing training and quality-
control efforts for consistency and interrater reli-
ability in delirium assessment. A training protocol
starts with instruction in basic aspects of delirium
assessment and detailed review of the study instru-
ments. A certiﬁcation process will foster competency
in the delirium assessor. The FOCUS-Cognition and
Dexlirium studies used Web-based training that
demonstrated conduct of the standardized assess-
ment on a model patient, and tested the reliability of
the trainee by asking them to rate a case based on
a videotaped interaction between a model patient and
the assessor. Validity of the trainee’s assessment is
further enhanced by an in-person training protocol in
which the trainee undertakes the assessment under the
supervision of a study physician. Because changes in
study personnel occur frequently, quality-control
efforts, such as co-rating in-person, videotaped inter-
views, or sequential examinations by different
personnel of the same patient on the same day, are
required throughout the duration of the study to
demonstrate reliability of the delirium assessments.
Although it is preferable to review every delirium
assessment in a structured way by using all available
evidence with a consensus panel, this might not be
feasible in large epidemiologic studies. The Dexlirium
and FOCUS-Cognition studies used a weekly or
monthly teleconference throughout the duration of
each study to discuss select delirium cases to improve
the competency of the assessors and to clarify any
issues related to assessment.
CONCLUSIONS
It is clear that standardization is a complex issue in
psychiatric epidemiology. At present, only clinicalAm J Geriatr Psychiatry -:-, - 2013
Davis et al.criteria can be used to deﬁne cases, although
biomarkers may be promising if validated in unse-
lected populations. One general consequence of not
identifying delirium accurately is misclassiﬁcation
bias, leading to a reduction in the observed effect size.
Thus, insufﬁcient attention to standardizing case-
ascertainment leads to loss of power in clinical studies.
It seems that many questions of direct clinical
relevance to the understanding and management of
delirium could be addressed by a convincingly
designed observational study. Starting with a cogni-
tively characterized, unselected base population,
tracking individuals longitudinally in and out of
hospital settings, is essential. Case-ascertainment
would beneﬁt from a more standardized applica-
tion, perhaps including a battery of objective tests
along with conventional subjective assessments, in
consensus conferences and/or algorithmic oper-
ationalization. Fluctuating symptoms are a core
feature of delirium, and this will not be reliablyAm J Geriatr Psychiatry -:-, - 2013captured without speciﬁc attention on how this
contributes to case-ascertainment. These efforts will
be rewarded by generating methodologically
rigorous clinical data applicable to the broad gener-
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